3.65
price up icon2.53%   0.09
after-market Dopo l'orario di chiusura: 3.65
loading

Puma Biotechnology Inc Borsa (PBYI) Ultime notizie

pulisher
01:50 AM

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)June 4, 2025 - BioSpace

01:50 AM
pulisher
May 28, 2025

Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors - sharewise

May 28, 2025
pulisher
May 26, 2025

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? - Yahoo Finance

May 26, 2025
pulisher
May 20, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Fly 25% But Investors Aren't Buying For Growth - simplywall.st

May 20, 2025
pulisher
May 17, 2025

Is Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Puma Biotechnology Inc (PBYI) Forecast: Revisiting The Past To Gain Insights For The Future - Stocksregister

May 17, 2025
pulisher
May 15, 2025

Puma Biotechnology's (NASDAQ:PBYI) Earnings Are Of Questionable Quality - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Puma Biotechnology targets $192M-$198M NERLYNX revenue for 2025 amid strategic efforts - MSN

May 14, 2025
pulisher
May 14, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Bought by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 12, 2025

Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock - Nasdaq

May 12, 2025
pulisher
May 12, 2025

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - MSN

May 12, 2025
pulisher
May 10, 2025

Puma Biotechnology First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Puma Biotech CCO Jeff Ludwig departs, no replacement named By Investing.com - Investing.com Canada

May 10, 2025
pulisher
May 10, 2025

Puma Biotech CCO Jeff Ludwig departs, no replacement named - Investing.com

May 10, 2025
pulisher
May 09, 2025

Puma Biotechnology, Inc. Announces Termination of Jeff J. Ludwig as Chief Commercial Officer - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Terminates Chief Commercial Officer - TipRanks

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Reports Positive Q1 2025 Earnings - TipRanks

May 09, 2025
pulisher
May 08, 2025

Puma Biotech Q1 2025 slides: NERLYNX revenue up 7% YoY despite quarterly decline - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Puma Biotech: Q1 Earnings Snapshot - The Washington Post

May 08, 2025
pulisher
May 08, 2025

Cautious Hold Rating on Puma Biotechnology Amid Declining Sales and Uncertain Trial Outcomes - TipRanks

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Puma Biotech Q1 2025 results miss forecasts By Investing.com - Investing.com UK

May 08, 2025
pulisher
May 08, 2025

Puma Biotechnology Reports First Quarter Financial Results - BioSpace

May 08, 2025
pulisher
May 08, 2025

Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Puma Biotech Q1 2025 results miss forecasts - Investing.com

May 08, 2025
pulisher
May 01, 2025

Check out these key findings about Puma Biotechnology Inc (PBYI) - Sete News

May 01, 2025
pulisher
Apr 30, 2025

Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Er-Kim Announces Exclusive Distribution Agreement with Puma - GlobeNewswire

Apr 30, 2025
pulisher
Apr 28, 2025

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Yahoo Finance

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - BioSpace

Apr 25, 2025
pulisher
Apr 23, 2025

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why - MSN

Apr 22, 2025
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):